Damian M Gallina

US Patent:

7157083, Jan 2, 2007

Filed:

Jan 16, 2002

Appl. No.:

10/050655

Inventors:

Damian J. Gallina - Erie PA, US

Assignee:

Surrogate Pharmaceutical Pathways, LLC - Erie PA

International Classification:

A61K 38/47
A61K 39/21

US Classification:

424 9461, 4242081

Abstract:

The present invention relates to hyaluronidase enzyme methods, vaccines and compositions for treating or preventing pathogenic infections, such as HIV, in a patient. The invention also relates to methods, vaccines and compositions for providing immunity against HIV infection in a patient comprising treating the patient with HIV virus or HIV infected cells that have been treated with hyaluronidase.

US Patent:

20070122432, May 31, 2007

Filed:

Dec 28, 2006

Appl. No.:

11/646663

Inventors:

Damian Gallina - Erie PA, US

International Classification:

A61K 39/395
A61K 39/12

US Classification:

424204100, 424130100

Abstract:

The present invention relates to hyaluronidase enzyme methods, vaccines and compositions for treating or preventing pathogenic infections, such as HIV, in a patient. The invention also relates to methods, vaccines and compositions for providing immunity against HIV infection in a patient comprising treating the patient with HIV virus or HIV infected cells that have been treated with hyaluronidase.

US Patent:

55831206, Dec 10, 1996

Filed:

Jun 2, 1995

Appl. No.:

8/471332

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715
C07H 504

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.

US Patent:

55299873, Jun 25, 1996

Filed:

Jun 2, 1995

Appl. No.:

8/471331

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.

US Patent:

56312423, May 20, 1997

Filed:

Jun 2, 1995

Appl. No.:

8/471334

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.

US Patent:

56249152, Apr 29, 1997

Filed:

Jun 2, 1995

Appl. No.:

8/471327

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.

US Patent:

56796552, Oct 21, 1997

Filed:

Jun 2, 1995

Appl. No.:

8/471323

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.

US Patent:

55831192, Dec 10, 1996

Filed:

Jun 2, 1995

Appl. No.:

8/471330

Inventors:

Damian J. Gallina - Erie PA

Assignee:

Patent Biopharmaceutics, Inc. - Erie PA

International Classification:

A61K 31715
C07H 504

US Classification:

514 54

Abstract:

This invention includes a pharmaceutical composition including a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically salt thereof. The invention also includes a method of treating disease of the cutis which includes applying to cutis tissues in need of such treatment a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier, urea, and hyaluronic acid or a pharmaceutically acceptable salt thereof, said disease having symptoms selected from the group consisting of inflammation, erythema, edema, papules, vesicles, macules, pustules, scaling, cracking, crusting, and lesions. The invention further includes methods for the treatment of psoriasis, eczema, dermatitis, herpetic conditions, acne, skin ulcers, genital herpes lesions and anorectal disease, which includes applying to tissues in need of such treatment a therapeutically effective amount of a composition including a pharmaceutically acceptable carrier, urea and hyaluronic acid or a pharmaceutically acceptable salt thereof.